ArticleFrontiers in immunology2022
Canakinumab for the treatment of autoinflammatory very early onset- inflammatory bowel disease.
Eliana Shaul et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it